SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/EFFE79B8240186A8497BB01DD7F4ABC3EEEC911003711EA85B5D40CCC21309E5846942D95D31294B834710F9DFA6CC4F>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/EFFE79B8240186A8497BB01DD7F4ABC3EEEC911003711EA85B5D40CCC21309E5846942D95D31294B834710F9DFA6CC4F
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/EFFE79B8240186A8497BB01DD7F4ABC3EEEC911003711EA85B5D40CCC21309E5846942D95D31294B834710F9DFA6CC4F
http://www.w3.org/2000/01/rdf-schema#comment
"Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3 7 and PARP in B- and T-lymphoblastic cells"
xsd:string
http://purl.uniprot.org/uniprot/#_D43E9E7464349263CBA9B633D4F91D498138A2EC65394E169D5553D58081AD0314270822B4BFDC7F7383FCCEA18F29A1
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/EFFE79B8240186A8497BB01DD7F4ABC3EEEC911003711EA85B5D40CCC21309E5846942D95D31294B834710F9DFA6CC4F
http://purl.uniprot.org/uniprot/B4DWA2
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/EFFE79B8240186A8497BB01DD7F4ABC3EEEC911003711EA85B5D40CCC21309E5846942D95D31294B834710F9DFA6CC4F
http://purl.uniprot.org/uniprot/#_B4DWA2-mappedCitation-20950443
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/EFFE79B8240186A8497BB01DD7F4ABC3EEEC911003711EA85B5D40CCC21309E5846942D95D31294B834710F9DFA6CC4F